Cebon J - Search Results

1

Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells.

Schnurr M, Toy T, Shin A, Hartmann G, Rothenfusser S, Soellner J, Davis ID, Cebon J, Maraskovsky E. Schnurr M, et al. Among authors: cebon j. Blood. 2004 Feb 15;103(4):1391-7. doi: 10.1182/blood-2003-06-1959. Epub 2003 Oct 9. Blood. 2004. PMID: 14551144 Free article.

2

Cytokine regulation of colony-stimulating factor (CSF) production in cultured human synovial fibroblasts. II. Similarities and differences in the control of interleukin-1 induction of granulocyte-macrophage CSF and granulocyte-CSF production.

Hamilton JA, Piccoli DS, Cebon J, Layton JE, Rathanaswani P, McColl SR, Leizer T. Hamilton JA, et al. Among authors: cebon j. Blood. 1992 Mar 15;79(6):1413-9. Blood. 1992. PMID: 1372187 Free article.

3

Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor.

Leizer T, Cebon J, Layton JE, Hamilton JA. Leizer T, et al. Among authors: cebon j. Blood. 1990 Nov 15;76(10):1989-96. Blood. 1990. PMID: 1700731 Free article.

4

Administration of pegylated recombinant human megakaryocyte growth and development factor to humans stimulates the production of functional platelets that show no evidence of in vivo activation.

O'Malley CJ, Rasko JE, Basser RL, McGrath KM, Cebon J, Grigg AP, Hopkins W, Cohen B, O'Byrne J, Green MD, Fox RM, Berndt MC, Begley CG. O'Malley CJ, et al. Among authors: cebon j. Blood. 1996 Nov 1;88(9):3288-98. Blood. 1996. PMID: 8896392 Free article. Clinical Trial.

5

Type I IFNs enhance the terminal differentiation of dendritic cells.

Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J. Luft T, et al. Among authors: cebon j. J Immunol. 1998 Aug 15;161(4):1947-53. J Immunol. 1998. PMID: 9712065

6

Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects.

Chen Q, Jackson H, Gibbs P, Davis ID, Trapani J, Cebon J. Chen Q, et al. Among authors: cebon j. Cancer Immunol Immunother. 1998 Dec;47(4):191-7. doi: 10.1007/s002620050520. Cancer Immunol Immunother. 1998. PMID: 9875671 Free PMC article.

7

A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A27-35 and Melan-A26-35.

Chen Q, Jackson H, Cebon J, Gibbs P, Davis ID, Trapani JA. Chen Q, et al. Among authors: cebon j. Melanoma Res. 2000 Feb;10(1):16-25. Melanoma Res. 2000. PMID: 10711636

8

A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancer.

Davis ID, Maher DW, Cebon JS, Green MD, Fox RM, McKendrick JJ, Rybak ME, Boyd AW. Davis ID, et al. Among authors: cebon js. Growth Factors. 2000;17(4):287-300. doi: 10.3109/08977190009028972. Growth Factors. 2000. PMID: 10801077 Clinical Trial.

9

MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.

Gibbs P, Hutchins AM, Dorian KT, Vaughan HA, Davis ID, Silvapulle M, Cebon JS. Gibbs P, et al. Among authors: cebon js. Melanoma Res. 2000 Jun;10(3):259-64. Melanoma Res. 2000. PMID: 10890380

10

Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.

Luft T, Rizkalla M, Tai TY, Chen Q, MacFarlan RI, Davis ID, Maraskovsky E, Cebon J. Luft T, et al. Among authors: cebon j. J Immunol. 2001 Sep 1;167(5):2529-37. doi: 10.4049/jimmunol.167.5.2529. J Immunol. 2001. PMID: 11509592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters